Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Carvajal, Alfonso
and
Martín Arias, Luis H.
1999.
Vol. 22,
Issue. ,
p.
45.
Yao, Jeffrey K
Reddy, Ravinder
and
van Kammen, Daniel P
2000.
Abnormal age-related changes of plasma antioxidant proteins in schizophrenia.
Psychiatry Research,
Vol. 97,
Issue. 2-3,
p.
137.
Edgar, P F
Douglas, J E
Cooper, G J S
Dean, B
Kydd, R
and
Faull, R L M
2000.
Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia.
Molecular Psychiatry,
Vol. 5,
Issue. 1,
p.
85.
Yao, Jeffrey K.
Reddy, Ravinder D.
and
van Kammen, Daniel P.
2001.
Oxidative Damage and Schizophrenia.
CNS Drugs,
Vol. 15,
Issue. 4,
p.
287.
Herken, H
Uz, E
Özyurt, H
Söğüt, S
Virit, O
and
Akyol, Ö
2001.
Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia.
Molecular Psychiatry,
Vol. 6,
Issue. 1,
p.
66.
Zhang, ZhiJun
Zhang, XiaoBin
Hou, Gang
Sha, WeiWei
and
Reynolds, Gavin P
2002.
The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism.
Journal of Psychiatric Research,
Vol. 36,
Issue. 5,
p.
317.
Ponizovsky, Alexander M.
Barshtein, Gregory
and
Bergelson, Lev D.
2003.
Biochemical Alterations of Erythrocytes as an Indicator of Mental Disorders: An Overview.
Harvard Review of Psychiatry,
Vol. 11,
Issue. 6,
p.
317.
Herken, Hasan
Erdal, M. Emin
Böke, Ömer
and
Savaş, Haluk A.
2003.
Tardive dyskinesia is not associated with the polymorphisms of 5-HT2A receptor gene, serotonin transporter gene and catechol-o-methyltransferase gene ⋆.
European Psychiatry,
Vol. 18,
Issue. 2,
p.
77.
Harvey, Brian H
and
Nel, Ané
2003.
Role of aging and striatal nitric oxide synthase activity in an animal model of tardive dyskinesia.
Brain Research Bulletin,
Vol. 61,
Issue. 4,
p.
407.
Zhang, Xiang Yang
Zhou, Dong Feng
Cao, Lian Yuan
Xu, Chang Qing
Chen, Da Chun
and
Wu, Gui Ying
2004.
The Effect of Vitamin E Treatment on Tardive Dyskinesia and Blood Superoxide Dismutase.
Journal of Clinical Psychopharmacology,
Vol. 24,
Issue. 1,
p.
83.
Fahn, Stanley
Jankovic, Joseph
Hallett, Mark
and
Jenner, Peter
2007.
Principles and Practice of Movement Disorders.
p.
479.
Bishnoi, Mahendra
Chopra, Kanwaljit
and
Kulkarni, Shrinivas K.
2009.
Co-administration of nitric oxide (NO) donors prevents haloperidol-induced orofacial dyskinesia, oxidative damage and change in striatal dopamine levels.
Pharmacology Biochemistry and Behavior,
Vol. 91,
Issue. 3,
p.
423.
Zai, Clement C.
Tiwari, Arun K.
Basile, Vincenzo
de Luca, Vincenzo
Müller, Daniel J.
Voineskos, Aristotle N.
Remington, Gary
Meltzer, Herbert Y.
Lieberman, Jeffrey A.
Potkin, Steven G.
and
Kennedy, James L.
2010.
Oxidative stress in tardive dyskinesia: Genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 34,
Issue. 1,
p.
50.
Heiser, P.
Sommer, O.
Schmidt, AJ
Clement, HW
Hoinkes, A.
Hopt, UT
Schulz, E.
Krieg, JC
and
Dobschütz, E.
2010.
Effects of antipsychotics and vitamin C on the formation of reactive oxygen species.
Journal of Psychopharmacology,
Vol. 24,
Issue. 10,
p.
1499.
Radonjić, Nevena V.
Knežević, Iva D.
Vilimanovich, Urosh
Kravić-Stevović, Tamara
Marina, Ljiljana V.
Nikolić, Tatjana
Todorović, Veljko
Bumbaširević, Vladimir
and
Petronijević, Nataša D.
2010.
Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: Long-term effects of perinatal phencyclidine administration.
Neuropharmacology,
Vol. 58,
Issue. 4-5,
p.
739.
Liu, Hong
Wang, Cui
Chen, Pin Hong
Zhang, Ben Shu
Zheng, You Lan
Zhang, Chong Xi
Meng, Hua Qing
Wang, Yu
Chen, Da Chun
Xiu, Mei Hong
Kosten, Thomas R
and
Zhang, Xiang Yang
2010.
Association of the manganese superoxide dismutase gene Ala–9Val polymorphism with clinical phenotypes and tardive dyskinesia in schizophrenic patients.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 34,
Issue. 4,
p.
692.
Yao, Jeffrey K.
and
Keshavan, Matcheri S.
2011.
Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View.
Antioxidants & Redox Signaling,
Vol. 15,
Issue. 7,
p.
2011.
Fahn, Stanley
Jankovic, Joseph
and
Hallett, Mark
2011.
Principles and Practice of Movement Disorders.
p.
415.
Revuelta, Gonzalo J.
Cloud, Leslie
Aia, Pratibha G.
and
Factor, Stewart A.
2011.
Hyperkinetic Movement Disorders.
p.
331.
Wu, Jing Qin
Chen, Da Chun
Xiu, Mei Hong
Tan, Yun Long
Yang, Fu De
Kosten, Thomas R.
and
Zhang, Xiang Yang
2013.
Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 46,
Issue. ,
p.
71.